Incretin-based therapies for type 2 diabetes: a focus on glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors
The effectiveness of tirzepatide for treating obesity is being evaluated in the SURMOUNT series of phase 3 RCTs, which, for the first time, demonstrated average weight reductions exceeding 20% with pharmacotherapy [23]
Saunders, Elliott-Sale, et al., -alanine supplementation to improve exercise capacity and performance: a systematic review and meta-analysis, Br J Sports Med, vol
The oxidation of derivatives of o-phenylenediamine
Delayed care, preventable complications, and frustration that builds over time
How often should glucose be monitored after starting GLP-1 therapy